Literature DB >> 29771635

Pathogenesis-based treatments in primary Sjogren's syndrome using artificial intelligence and advanced machine learning techniques: a systematic literature review.

Nathan Foulquier1,2, Pascal Redou1, Christophe Le Gal1, Bénédicte Rouvière2,3, Jacques-Olivier Pers3, Alain Saraux3,4.   

Abstract

Big data analysis has become a common way to extract information from complex and large datasets among most scientific domains. This approach is now used to study large cohorts of patients in medicine. This work is a review of publications that have used artificial intelligence and advanced machine learning techniques to study physio pathogenesis-based treatments in pSS. A systematic literature review retrieved all articles reporting on the use of advanced statistical analysis applied to the study of systemic autoimmune diseases (SADs) over the last decade. An automatic bibliography screening method has been developed to perform this task. The program called BIBOT was designed to fetch and analyze articles from the pubmed database using a list of keywords and Natural Language Processing approaches. The evolution of trends in statistical approaches, sizes of cohorts and number of publications over this period were also computed in the process. In all, 44077 abstracts were screened and 1017 publications were analyzed. The mean number of selected articles was 101.0 (S.D. 19.16) by year, but increased significantly over the time (from 74 articles in 2008 to 138 in 2017). Among them only 12 focused on pSS but none of them emphasized on the aspect of pathogenesis-based treatments. To conclude, medicine progressively enters the era of big data analysis and artificial intelligence, but these approaches are not yet used to describe pSS-specific pathogenesis-based treatment. Nevertheless, large multicentre studies are investigating this aspect with advanced algorithmic tools on large cohorts of SADs patients.

Entities:  

Keywords:  Artificial intelligence; Sjogren's syndrome; advanced machine learning techniques; systematic literature review

Mesh:

Year:  2018        PMID: 29771635      PMCID: PMC6314425          DOI: 10.1080/21645515.2018.1475872

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  23 in total

1.  Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome.

Authors:  Mengru Liu; Xinyu Wu; Xu Liu; Jing He; Yin Su; Jianping Guo; Zhanguo Li
Journal:  Hum Immunol       Date:  2015-09-30       Impact factor: 2.850

2.  Benchmarking human epithelial type 2 interphase cells classification methods on a very large dataset.

Authors:  Peter Hobson; Brian C Lovell; Gennaro Percannella; Mario Vento; Arnold Wiliem
Journal:  Artif Intell Med       Date:  2015-08-13       Impact factor: 5.326

Review 3.  Treatment of primary Sjögren syndrome.

Authors:  Alain Saraux; Jacques-Olivier Pers; Valérie Devauchelle-Pensec
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

4.  Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

Authors:  Pilar Brito-Zerón; Nihan Acar-Denizli; Margit Zeher; Astrid Rasmussen; Raphaele Seror; Elke Theander; Xiaomei Li; Chiara Baldini; Jacques-Eric Gottenberg; Debashish Danda; Luca Quartuccio; Roberta Priori; Gabriela Hernandez-Molina; Aike A Kruize; Valeria Valim; Marika Kvarnstrom; Damien Sene; Roberto Gerli; Sonja Praprotnik; David Isenberg; Roser Solans; Maureen Rischmueller; Seung-Ki Kwok; Gunnel Nordmark; Yasunori Suzuki; Roberto Giacomelli; Valerie Devauchelle-Pensec; Michele Bombardieri; Benedikt Hofauer; Hendrika Bootsma; Johan G Brun; Guadalupe Fraile; Steven E Carsons; Tamer A Gheita; Jacques Morel; Cristina Vollenveider; Fabiola Atzeni; Soledad Retamozo; Ildiko Fanny Horvath; Kathy Sivils; Thomas Mandl; Pulukool Sandhya; Salvatore De Vita; Jorge Sanchez-Guerrero; Eefje van der Heijden; Virginia Fernandes Moça Trevisani; Marie Wahren-Herlenius; Xavier Mariette; Manuel Ramos-Casals
Journal:  Ann Rheum Dis       Date:  2016-11-29       Impact factor: 19.103

5.  Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren's syndrome in Korea: A nationwide, population-based study.

Authors:  Hyun Jung Kim; Kyoung Hoon Kim; Hoo Jae Hann; Seungjin Han; Yuri Kim; Sang Hyuk Lee; Dong Sook Kim; Hyeong Sik Ahn
Journal:  Semin Arthritis Rheum       Date:  2017-03-08       Impact factor: 5.532

6.  [Promising diagnostic model for systemic lupus erythematosus using proteomic fingerprint technology].

Authors:  Zhuo-chun Huang; Yun-ying Shi; Bei Cai; Lan-lan Wang; Yong-kang Wu; Bin-wu Ying; Wei-hua Feng; Chao-jun Hu; Yong-zhe Li
Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban       Date:  2009-05

7.  Unbiased estimation of biomarker panel performance when combining training and testing data in a group sequential design.

Authors:  Nabihah Tayob; Kim-Anh Do; Ziding Feng
Journal:  Biometrics       Date:  2016-02-04       Impact factor: 2.571

8.  Common variants near IKZF1 are associated with primary Sjögren's syndrome in Han Chinese.

Authors:  Susu Qu; Yang Du; Suhua Chang; Liyuan Guo; Kechi Fang; Yongzhe Li; Fengchun Zhang; Kunlin Zhang; Jing Wang
Journal:  PLoS One       Date:  2017-05-26       Impact factor: 3.240

9.  Clinical course, prognosis, and cause of death in primary Sjögren's syndrome.

Authors:  Ildiko Fanny Horvath; Antonia Szanto; Gabor Papp; Margit Zeher
Journal:  J Immunol Res       Date:  2014-05-20       Impact factor: 4.818

10.  Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use.

Authors:  Sofia Fragkioudaki; Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.